Desmoplastic melanoma of the nail

Annals of Plastic Surgery

Volumn 50, Issue 6, 2003, Pages 658-662

  Parodi, PierCamillo ^a,c   Scott, Cathryn A ^a   De Biasio, Fabrizio ^a   Pezzini, Ilaria ^b   Pertoldi, Barbara ^a   Beltrami, Carlo A ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b S ANNA HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; DESMOPLASTIC MELANOMA; DIAGNOSTIC ERROR; FINGER AMPUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MALE; MELANOMA; NAIL DISEASE; PRIORITY JOURNAL;

ADULT; AMPUTATION; BIOPSY, NEEDLE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; NAILS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK ASSESSMENT; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0037607310     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SAP.0000041481.21471.A9     Document Type: Article

References (28)

1. Banfield CC, Redburn JC, Dawber RPR. The incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regions. Br J Dermatol. 1998;139:276.
2. Banfield CC, Dawber RPR. Nail melanoma: a review of the literature with recommendations to improve patient management. Br J Dermatol. 1999;141:628.
3. Blessing K, Kernohan NM, Park KGM. Subungual malignant melanoma: clinicopathological features of 100 cases. Histopathology. 1991;19:425.
4. Kato T, Suetake T, Sugiyama Y, et al. Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol. 1996;134:383.
5. Rongioletti F, Gambini C, Semino MT, et al. Desmoplastic and neurotropic subunguial melanoma. Ann Dermatol Venereol. 1995;122(10):707.
6. Patterson RH, Helwig EB. Subungual malignant melanoma: a clinical-pathologic study. Cancer. 1980;46:2074.
7. Pearce M. Subunguial desmoplastic melanoma in an aboriginal woman. Med J Aust. 1995;162:611.
8. Hara M, Kato T, Tagami H. Amelanotic acral melanoma masquerading as fibrous histiocytic tumours. Three case reports. Acta Dermatol Venereol. 1993;73:283.
9. Moreno A, Lamarca J, Martinez R, et al. Osteoid and bone formation in desmoplastic malignant melanoma. J Cutan Pathol. 1986;13:128.
10. Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer. 1971;28:914.
11. Quinn MJ, Crotty KA, Thompson JF, et al. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer. 1998;83:1128.
12. Anstey A, McKee P, Wilson-Jones E. Desmoplastic malignant melanoma: a clinicopathological study of 25 cases. Br J Dermatol. 1993;129:359.
13. Skelton HG, Smith KJ, Laskin WB, et al. Desmoplastic malignant melanoma. J Am Acad Dermatol. 1995;32:717.
14. Payne WG, Kearney R, Wells K, et al. Desmoplastic melanoma. Am Surg. 2001;67:1004.
15. Elder DE, Murphy GF. Melanocytic tumors of the skin. In: Rosai J, Sobin LH, eds. Atlas of tumor pathology. 3rd series. Washington, DC: Armed Forces Institute of Pathology; 1991:103-205.
16. Reed RJ, Leonard DD. Neurotropic melanoma (a variant of desmoplastic melanoma). Am J Surg Pathol. 1979;3:301.
17. Smithers BM, McLeod GR, Little JH. Desmoplastic neural transforming and neurotropic melanoma. A review of 45 cases. Aust N Z J Surg. 1990;60:967.
18. Weinzweig N, Tuthill RJ, Yerman RJ. Desmoplastic malignant melanoma: a clinicopathologic review. Plast Reconstr Surg. 1995;95:548.
19. Perrin C, Michelis JF, Pisani A, et al. Anatomic distribution of melanocytes in normal nail matrix. An immunohistochemical investigation. Am J Dermatopathol. 1997; 19:462.
20. Spencer JM. Nail apparatus melanoma. Lancet. 1999;353: 84.
21. Carlson JA, Dickersin GR, Sober AJ, et al. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 28 cases. Cancer. 1995;75:478.
22. Harris GR, Shea CR, Horenstein MG, et al. Desmoplastic (sclerotic) nevus. An underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999;23:786.
23. Orchard GE. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem. 2000;32:475.
24. Skelton HG, Maceira J, Smith KJ, et al. HMB45 negative spindle cell malignant melanoma. Am J Dermatopathol. 1997;19:580.
25. Fetsch JF, Michal M, Miettinen M. Pigmented (melanotic) neurofibroma: a clinicopathologic and immunohistochemical analysis of 19 lesions from 17 patients. Am J Surg Pathol. 2000;24:331.
26. Koch MB, Shih IM, Weiss SW, Folpe AL. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Am J Surg Pathol. 2001; 25:58.
27. Kanik AB, Yaar M, Bhawan J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol. 1996;23:205.
28. Tseng JF, Tanabe KK, Gadd MA, et al. Surgical management of primary cutaneous melanomas of the hands and feet. Ann Surg. 1997;225:544.